Molecular characterization of a novel ring 6 chromosome using next generation sequencing by unknown
RESEARCH Open Access
Molecular characterization of a novel ring 6
chromosome using next generation
sequencing
Rui Zhang1*, Xuan Chen1, Peiling Li2, Xiumin Lu1, Yu Liu1, Yan Li1, Liang Zhang3, Mengnan Xu4 and David S. Cram4*
Abstract
Background: Karyotyping is the gold standard cytogenetic method for detection of ring chromosomes. In this
study we report the molecular characterization of a novel ring 6 (r6) chromosome in a six-year-old girl with severe
mental retardation, congenital heart disease and craniofacial abnormalities.
Methods: Cytogenetic analysis was performed by conventional karyotyping. Molecular genetic analyses were
performed using high-resolution chromosome microarray analysis (CMA) and next generation sequencing (NGS).
OMIM, UCSC and PubMed were used as reference databases to determine potential genotype to phenotype
associations.
Results: Peripheral blood and skin fibroblast karyotyping revealed the presence of a dominant cell line,
46,XX,(r6)(p25.3;q27) and a minor cell line 45,XX,-6. Molecular karyotyping using NGS identified 6p25.3 and
6q27 subtelomeric deletions of 1.78 Mb and a 0.56 Mb, respectively. Based on the known genes located
within the r6 deletion interval 6q25.3-pter, genotype to phenotype association studies found compelling
evidence to suggest that hemizygous expression of disease genes FOXC1, FOXF2, IRF4 and GMDS was the
main underlying cause of the patient’s phenotype. We further speculate that the severity of the patient’s
symptoms may have been exacerbated by low-level instability of the r6 chromosome.
Conclusion: This is the first report of a novel r6 chromosome characterized at the molecular level using NGS.
Keywords: Karyotyping, Ring chromosome, Chromosome microarray analysis, Copy number variation, Next generation
sequencing
Background
Human ring chromosomes were first reported in 1956
from cytogenetic analyses of tumor cells [1]. Ring chro-
mosomes can involve any of the 24 chromosomes and
are recognized in approximately 1 in 25,000 conceptions
by karyotyping [2]. Random de novo recombination
events during gametogenesis or early pre-implantation
embryo development are believed to be responsible for
the formation of ring chromosomes. The most common
mechanism of ring chromosome formation usually either
involves breakage near the termini of the short and long
arms or breakage of one of the arms, followed by a subse-
quent fusion to generate a circular shortened chromosome
with two or one terminal deletions [3, 4]. Occasionally,
telomere-telomere fusions can also occur without the loss
of any significant chromosomal material to generate
complete ring chromosomes [3, 5, 6]. In general, the overall
phenotype of the patients with ring chromosomes are
highly variable, but generally overlap with phenotypes of
known chromosome disease syndromes associated with
similar interstitial copy number variations (CNVs) [4].
De novo ring chromosome 6 (r6) is a rarely observed
structural abnormality compared to other types of ring
chromosomes, with just over 30 case reports published
in the literature [7]. Several r6 cases have been serendip-
itously detected by karyotyping during routine prenatal
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diagnosis [8, 9]; however, the majority of cases have been
revealed postnatally following genetic investigation of
children with unexplained clinical features. The most
common r6 variants reported involve terminal 6p dele-
tions extending to p25 or p24 in addition to 6q deletions
extending to q26 or q27 [10–15]. In a review of selected
r6 cases [7], phenotypes were highly variable, with the
most consistent clinical features involving mental and de-
velopmental retardation, in association with facial dys-
morphic features including microcephaly, microgathia,
short neck, flat or broad nasal bridge, epicanthus bilateral
and malformations of the ocular and auditory systems.
Apart from karyotyping and fluorescent in situ hybridization
with 6p and 6q probes, most reported cases pre-date the avail-
ability of high resolution molecular techniques such as array
comparative genomic hybridization (CGH) and next gener-
ation sequencing (NGS) and thus determination of precise
genotype to phenotype associations has been limited. Recently,
by applying an NGS method called copy number variation
sequencing (CNV-Seq), we were able to identify the precise
terminal deletion intervals in three cases of r14, r22 and r18
chromosomes [16]. In this study, using both array CGH
and CNV-Seq, we report a comprehensive molecular
characterization of a novel r6 chromosome in a six-year-
old girl with severe intellectual disability, congenital heart
disease and dysmorphic craniofacial features.
Results
Clinical evaluation of the patient
A 31-year-old father and mother presented at our pre-
natal diagnostic department for clinical assessment of
their six-year-old daughter with unexplained dysmorphic
facial features and severe intellectual disability. In review
of the family, both parents were healthy and there was
no history of genetic diseases or birth defects. Their
daughter was born at the gestational age of 40 weeks via
emergency caesarian section with a low birth weight of
2200 grams.
When examined at the age of 6.5 years, her weight was
14.00 kg (< third percentile), length 103 cm (< third per-
centile), head circumference 42 cm and chest circumfer-
ence 51 cm. A thorough physical examination revealed
microcephaly, a low posterior hairline, dysmorphic facial
features including microphthalmia, epicanthus, leukoma,
nystagmus, iridogoniodysgenesis, a down slanting brow
and canthus, a flat nasal bridge and tooth agenesis. She
also had a short neck and flat occiput, widely spaced nip-
ples, short and an inturned recurved little finger (Fig. 1).
By two-dimensional color-doppler echocardiography, con-
genital heart disease was detected involving an ostium
secundum defect (left to right shunt), patent ductus arter-
iosus (left to right shunt), pulmonary stenosis, left superior
vena cava residues and coronary sinus distention. In
addition, the girl exhibited developmental delay, mental
retardation and speech difficulties, and her overall intellec-
tual ability was judged to be equivalent to that of a one-
year old infant. The girl was able to walk, but her gait was
unsteady. She also presented with hyperactivity and gatism.
Genetic investigation of the child
Conventional cytogenetic analysis of peripheral blood
collected from the parents revealed normal karyotypes.
Unexpectedly, their daughter returned a 46,XX,r(6)
(p25.3q27) karyotype, involving one copy of a ring 6
chromosome and one copy of a normal chromosome 6. A
further blood sample and a skin punch biopsy sample was
collected from the patient to investigate the possibility of
tissue mosaicism. From testing 88 lymphocytes, the karyo-
type was 46,XX,r(6)(p25.3;q27)[81]/45,XX,-6[7], revealing
8 % of cells without the r6 chromosome (Fig. 2a). Simi-
larly, from testing 50 skin fibroblasts, the karyotype was
46,XX,r(6)(p25.3;q27)[47]/45,XX,-6[3] indicating that 6 %
of cells had lost the r6 chromosome (Fig. 2b).
To determine the molecular structure of the r6
chromosome in more detail, high-resolution array CGH
was performed on genomic DNA extracted from periph-
eral blood (Fig. 3). Genome-wide profiling for patho-
genic copy number changes by array CGH detected a
1.78 Mb 6p25.3-pter deletion. However, on chromosome
6, there was also evidence of a small intra-chromosomal
deletion at 6q22.31 and a small terminal 6q27 deletion,
respectively, although the “call” by the software was not
confident due to the lack of informative probes in these
two regions. To confirm the array CGH results, we also
performed NGS using copy number variation sequen-
cing (CNV-Seq). Sequence data analysis revealed four
CNVs, namely a 0.66 Mb 5q11-12 duplication, a 1.78
Fig. 1 Facial features of the patient. Craniofacial abnormalities (a).
Teeth agenesis (b). Ocular abnormalities (c). Shortened and (d).
incurred small finger
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Mb 6p25-pter deletion, a 0.26 Mb 6q22.31 deletion and
a 0.56 Mb 6q27-qter deletion (Fig. 4).
Searches of the UCSC and OMIM databases for refer-
ence and disease genes were performed for the four CNVs
defined by CNV-Seq to identify the genes encoded in these
intervals (Fig. 3). Within the 6p25-pter deletion interval 13
reference genes were identified; namely, LOC285766,
DUSP22, IRF4, EXOC2, HUS1B, LOC101927691,
LOC285768, FOXQ1, FOXF2, MIR6720, FOXCUT, FOXC1
and GMDS, where IRF4 and FOXC1 have been classified as
OMIM disease genes. The 6q22.31 deletion interval
encoded the gene NKAIN2, which has no known disease
association. Within the 6q27-qter deletion interval there
were 10 genes identified, namely; LOC102724511,
LOC154449, LOC285804, FLJ38122, DLL1, FAM120B,
MIR4644, PSMB1, TBP and PDCD2, where only TBP has
been classified as an OMIM disease gene. The 5q11-12 du-
plication region contained no known genes. Literature
searches found no evidence that this region is associated
with pathogenicity, and on this basis, the 5q11-12 duplica-
tion was deemed to be benign.
Discussion
This study presents detailed cytogenetic and molecular
analyses to characterize a novel r6 chromosome originally
detected by conventional karyotyping in a six-year-old girl.
More extensive karyotyping of blood and skin cells
showed that while the vast majority of cells had one copy
of chromosome 6 and one copy of the r6 chromosome, a
minority of cells in both tissues (6–8 %) had lost the r6
chromosome, resulting in monosomy 6. Since the blood
karyotyping was performed on short-term cultures, and
that long term cultures of skin fibroblasts did not increase
the incidence of r6 chromosome loss, we conclude that
the mosaic karyotype most likely originated in vivo due
to r6 instability. High-resolution genomic analysis by
array CGH and CNV-Seq was used to survey genome-
wide CNVs and, simultaneously analyze the terminal
CNVs associated with the r6 chromosome. The most
significant CNVs identified were 1.76 Mb (6p) and 0.56
Mb (6q) subtelomeric deletions of the r6 chromosome.
In comparison to other cytogenetically defined r6 chro-
mosomes, this novel variant has the smallest 6p deletion
involving p25.3-pter, whereas all other r6 variants reported
to date have more extensive deletions, involving 25p-pter
or 24p-pter [7].
By comparison, NGS provided a much higher resolution
analysis of the patient’s DNA than array CGH, allowing pre-
cise definition of genome-wide CNVs and the subtelomeric
CNVs associated with the r6 chromosome. While both
Fig. 2 Tissue karyotyping. a Blood lymphocytes, 46,XX,r6(p25.3;q27)[81]/45,XX,-6[7]. b Skin fibroblasts, 46,XX,r6(p25.3;q27)[47]/45,XX,-6[3]. Loss of
the r6 chromosome was seen in 8 % of blood lymphocytes and 6 % of skin fibroblasts
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Fig. 3 (See legend on next page.)
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NGS and array CGH identified the 1.76 Mb 6p subtelo-
meric deletion, array CGH missed the 0.56 Mb 6q subtelo-
meric deletion. In addition, NGS was able to accurately
quantitate the copy number changes of the deletions. The
difference in resolving power between the two techniques
for the subtelomeric regions of chromosome 6 was attribut-
able to the increased data points generated by NGS, which
is based on analysis of randomly distributed sequencing
reads whereas array CGH probes are more targeted to dis-
ease genes located throughout the genome. For example, to
detect the 0.56 Mb 6q deletion, NGS utilized multiple data
points provided by 28 contiguous 20 kb sequencing bins,
which contain on average of 30–35 reads per bin [16]. In
contrast, within this region, the array CGH platform only
contained five probes and, collectively, the individual probe
results were not informative for confidently calling a dele-
tion. Thus, based on these findings, we speculate that NGS
will not only be a useful technique for detecting additional
genome-wide CNVs contributing to disease phenotypes,
but also a preferable technology for precisely delineating
CNVs at the terminal ends of chromosomes, with particular
application to the analysis of all types of ring chromosomes.
Further, based on similar principles, NGS technology may
also have useful application for the diagnosis of unbalanced
translocations with small subtelomeric duplications and de-
letions and, aid in defining more precise phenotypes associ-
ated with these structural re-arrangements.
The cytogenetic and molecular karyotypes defined
provided a sound basis for exploring possible genotype
to phenotype correlations in the patient studied. The
6p25.3 microdeletion syndrome is a known chromosome
disease with well-described clinical features, consisting
of developmental delay, mental retardation, language im-
pairment, hearing loss, and ophthalmologic, cardiac, and
craniofacial abnormalities [17–20]. Further, patients with
unbalanced translocations involving deletion of the 6p
25.3 region, also display a similar phenotype [21]. These
clinical features of all patients with interstitial deletions
of 6p25.3 closely overlap with the clinical features of pa-
tients that carry a r6 chromosome [7] and strongly sug-
gest that the main phenotypes displayed are primarily
due to hemizygous expression of genes within the
6p25.3-pter interval. Therefore, in order to explore
genotypic associations with congenital heart disease,
mental retardation and craniofacial abnormalities ob-
served in the six-year-old girl, we specifically analyzed
the known function of the genes encoded within the
subtelomeric 6p25.3 region (Table 1).
The FOX family are a group of transcription factors
characterized by a conserved 110 amino acid DNA bind-
ing domain that play an important synergistic role in
embryonic development, tissue-specific gene expression,
morphogenesis [22] as well as cardiovascular develop-
ment [23]. Four members of the FOX gene family
FOXC1, FOXF2, FOXQ1 and FOXCUT are encoded by
genes within the 6p25.3-pter interval (Fig. 4). RNA stud-
ies found that both FOXC1 and FOXF2 are highly
expressed in the left ventricle [24, 25] whereas FOXQ1
was not expressed in the heart [22]. Loss of function
studies comparing different models with normal or ab-
normal heart development have also shown that lower
levels of several FOX proteins, including FOXC1, is
strongly associated with the pathogenesis of heart fail-
ure. Further, studies of compound FOXC1 and FOXC2
mutant embryos identified a wide spectrum of cardiac
abnormalities, including cardiac inflow and outflow dys-
plasia and abnormal formation of the epicardium [26].
Moreover, patients with FOXC1 specific mutations often
have identifiable cardiac abnormalities [27]. Based on
these limited studies, we speculate that haplo-deficiency
of FOXC1 and, possibly FOXF2, may contribute to the
complex heart abnormalities seen in the r6 patient.
The r6 patient also exhibited severe mental retardation
and speech delay. Several studies suggest that reduced
expression of genes FOXC1, FOXF2 and GMDS which
are located in the 6p25.3-pter deletion interval, affect
normal brain and central nervous system (CNS) devel-
opment [27–31]. In FOXC1 null mice, significant cere-
bellum abnormalities were observed [27]. Brain MRI
scans of mental retardation patients with known FOXC1
gene deletions or missense mutations show a range of
different cerebellum malformations including mega cis-
terna magna or cerebellar vermis hypoplasia [27, 28]. In
other studies, FOXF2 was identified as a regulator of
neural outgrowth through the modulation of nuclear ac-
tive Akt [29] and FOXF1 was shown to be an important
developmental regulator of the CNS [30]. Mutations in
the GMDS gene which encodes an enzyme responsible
(See figure on previous page.)
Fig. 3 High-resolution analysis of r6 microdeletions and associated genes. a CMA and NGS copy number plots for chromosome 6. The array CGH
plot is shown as copy number (Y-axis) versus cytogenetics co-ordinates. Red dots indicate chromosomal gain and green dots indicate chromosomal
loss. The NGS chromosome 6 plot is shown as log2 mean CNV (Y-axis) versus 20 kb sequencing bins (X-axis). The blue line along chromosome 6 tracks
the mean CNV. The upper dashed line represents a 100 % chromosome gain [log2(1.5)] and the lower dashed line represents a 100 % chromosome
loss [log2(0.5)]. Red lines indicate regions of repetitive sequences and the black box marks the centromere. Three microdeletions were identified (red
dashed boxes); 6p25.3-pter (detected by CMA and NGS), 6q22.31 (detected by NGS) and 6q27-qter (detected by NGS). b Gene deletion intervals. The
relative size and position of UCSC database reference genes in the three intervals is shown. Open boxes represent non-disease genes and solid black
boxes represent disease-genes, according to OMIM database
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for protein fucosylation, have also been found in a zebra-
fish model to cause defects in neuronal differentiation,
axon branching and synapse formation [31]. In one key
study, the severity of mental retardation in patients was
found to be strongly associated with the size and pos-
ition of FOXC1 deletions and whether they extended fur-
ther to encompass exons of the nearby GMDS gene [27].
Taken together, these collective studies point to haplo-
deficiency of FOXC1 and GMDS as the primary genes
responsible for the severe mental disabilities exhibited
by the r6 patient.
In regard to physical abnormalities of the patient
(Fig. 1), craniofacial features were highly dysmorphic,
with eye and tooth abnormalities particularly prominent.
Fig. 4 CNV-Seq analysis of patient genomic DNA. Twenty-four chromosome plots are shown as log2 mean CNV (Y-axis) versus 20kb sequencing bins
(X-axis). Chr 23 = Chr X; Chr 24 = Chr Y. The blue line along the length of each chromosome tracks the mean CNV. The upper dashed line represents a
100 % chromosome gain [log2(1.5)] and the lower dashed line represents a 100 % chromosome loss [log2(0.5)]. Red lines indicate regions of repetitive
sequences and the black box marks the centromere. Dashed red boxes indicate significant CNVs identified on chromosomes 5 and 6
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Based on several studies, FOXC1 is believed to be the
primary causative gene, although there is evidence that
FOXF2 and IF4 genes also contribute to the phenotype.
Human FOXC1 heterozygous mutations are well known
to affect eye development, causing a spectrum of ocular-
associated anomalies including glaucoma and Axenfeld-
Rieger syndrome [27, 32–34]. In mice, heterozygous
mutations of FOXF2 are associated with iridocorneal
angle changes [35] and in one patient studied, partial iris
hyperplasia was present even when the 6p deletion did
not encompass the FOXC1 gene [36]. Thus hemizygous
expression of FOXC1 and FOXF2 may explain the cor-
neal abnormalities, iridogoniodysgenesis and nystagmus
observed in the patient. Further, the gene IRF4 is im-
portant for human pigmentation of the hair skin and
eyes [37, 38] and therefore loss of one copy of this gene
may explain leukoma identified in the eyes of the pa-
tient. Lastly, during embryonic tooth development in
rodents from the bud to differentiation stage, FOXF2
mRNA was detected in the mesenchyme surrounding
tooth germ cells, especially in the dental follicle adjacent
to the outer enamel epithelium [30]. Thus, loss of one
copy of the FOXF2 gene may also be associated with the
teeth agenesis exhibited by the patient. These studies
suggest that while hemizygous expression of FOXC1 is
probably the main cause of the craniofacial abnormal-
ities in the patient, loss of one copy of the FOXF2 and
IRF4 genes may have significantly exacerbated the sever-
ity of the facial abnormalities.
Based on a survey of the available literature, the evi-
dence presented strongly points to haplodeficiency of
the FOXC1 gene as the major contributing factor to the
overall phenotype of the patient and that hemizygous ex-
pression of FOXF2, IRF4 and GMDS genes may further
contribute to the phenotype. However, the phenotype of
the patient was severer than that exhibited by other r6
patients reported with more extensive 6p and 6q dele-
tions [7], in particular, growth retardation and mental
development was severe. Within the 6q27 deletion
interval there were 10 genes, with only TBP recognized
as an OMIM disease gene. Trinucleotide repeat expan-
sion of the TBP gene has been shown to cause the
neurological disorder spinocerebellar ataxia 17 [39].
However, since patients with r6 chromosomes involving
both 6p and 6q terminal deletions exhibit a very similar
phenotype to patients with r6 chromosomes involving
only 6p terminal deletions [7], we argue that the 6q ter-
minal deletion carried by the child was unlikely to have
significantly contributed to the severer phenotype. This
leaves the finding of r6 mosaicism in this patient as the
most likely explanation. In previous studies, evidence
suggests that growth and developmental delay com-
monly seen in patients carrying autosomal ring chromo-
somes is due to mosaicism caused by instability of the
ring chromosome [4, 40, 41]. On this basis, we speculate
that low-level r6 mosaicism, probably originating early
in neonatal development, has exacerbated the severity of
the symptoms exhibited by this patient, which appear to
be primarily caused by the 6p25.3-pter deletion event.
Methods
Study oversight
The research study was approved by the Medical Ethics
Committee of the Second Affiliated Hospital of Harbin
Medical University (Approval Number KY2016-154).
Cytogenetic studies
Blood cell karyotyping was performed according to
standard methods [42]. White blood cells were cultured
for 72 h in PHA supplemented Serum Free Culture
Medium (Guangzhou He Neng Bio Technology Co.,
Ltd). Skin puncture biopsies were taken from the ab-
dominal skin, placed in PBS, cut into 0.5 mm3 pieces,
transferred into a Dispase II solution and incubated
overnight at 4 °C [43]. Epidermal fibroblasts were then
cultured at 37 °C under 5 % CO2 and 90 % humidity for
12 days in PHA supplemented BIOAMFTM-3 media
(Biological Industries Israel Beit Haemek Ltd). Following
colcemid treatment, G banded metaphase chromosome
spreads of blood and skin cells were prepared. For detec-
tion of mosaicism, a minimum of 50 cells were karyotyped.
Chromosome microarray analysis
Array CGH was performed using 8 × 60 K commercial
arrays (Agilent) according to the manufacturer’s recom-
mended protocol. After DNA labeling, hybridization and
washing, slides were scanned using an Agilent microarray
scanner, and raw data extracted using Feature Extraction
Software at the default CGH parameter settings. Putative
copy number alteration intervals in each sample were
identified using Agilent Genomic Workbench v6.5.0.18
software. Cy5/Cy3 ratios were converted into log2-
transformed values and the Aberration Detection Method
Table 1 Genotype to phenotype associations
Main clinical findings in the patient Gene References
Severe mental retardation, speech delay FOXC1 [27–29]
FOXF2 [30]
GMDS [31]
Congenital heart disease, ostium secundum defect,
patent ductus arteriosus, pulmonary stenosis, left




Teeth agenesis FOXF2 [30]
Leukoma IRF4 [37, 38]
Iridogoniodysgenesis anomaly and nystagmus FOXC1 [27]
FOXF2 [35]
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2 algorithm applied at threshold 6.0 to identify CNVs,
based on the following criteria: ≥ 5 probes per CNV inter-
val and a minimum absolute average log2 ratio of ≥ 0.38
for the test region.
Next generation sequencing
NGS was performed by using copy number variation
sequencing (CNV-Seq) as previously described [16, 44].
DNA libraries were constructed and subjected to mas-
sively parallel sequencing on the Hi Seq2500 platform
(Illumina) to generate 36 bp sequencing reads. High qual-
ity reads (2.8–3.2 million) were mapped to the hg19 refer-
ence genome [45], allocated to 20 kb sequencing bins and
the mean CNV plotted for each chromosome [44].
Consent
The parental guardians provided written informed
consent on behalf of the child for publication of this
Research Article and the accompanying image. A copy
of the written consent form is available for review by
the Editor-in-Chief of this journal.
Conclusions
In this study, we demonstrate molecular utility of NGS
as a high resolution technology for molecular
characterization of subtelomeric deletions associated
with a novel r6 chromosome. Based on the defined
genotype, we attributed the severe mental retardation,
congenital heart disease and craniofacial abnormalities
observed in the patient largely to hemizygous expression
of FOXC1, FOXF2 and GMDS genes within the 6p25.3-
pter interval, although circumstantial evidence suggested
that in vivo instability of the r6 chromosome exacer-
bated the severity of the phenotype. With ethical ap-
proval and patient consent, further tissue studies are
needed to better understand the genetic basis of the
variable and complex phenotypes observed in rare pa-
tients with r6 chromosomes.
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